Blog

$2,340 for a Covid-19 treatment?

Yesterday US pharmaceutical company, Gilead announced that they will charge an extraordinary $2,340 for a five-day treatment course for the drug remdesivir, which is being used as a treatment for Covid-19. The drug has been developed with substantial amounts of public money in the US, with a reported $70.5 million of public investment

South African movements are building a Climate Justice Charter from below

Despite a temporary dip in carbon emissions due to the coronavirus pandemic, scientific calculations shows that it is highly likely that 2020 will still be the world’s hottest year on record.

6 ways to mark Windrush Day and challenge the racist hostile environment

Today is Windrush Day, marking the day 72 years ago when the Empire Windrush ship arrived at Tilbury Docks and gave its name to a generation of migrants from the Caribbean. It’s a day of celebration – but also necessarily a day of confronting injustice. Here's a reminder of why and how we can re-commit to demanding justice for the Windrush generation and demanding an end to the hostile environment for migrants, once and for all. 

Latest news

Groups in more than 90 countries warn ISDS system could be used to claim billions from governments over pandemic protections

Countries could be facing a wave of cases from transnational corporations suing governments over actions taken to respond to the Covid pandemic using a system known as investor-state dispute settlement, or ISDS. 630 organisations from across the world, representing hundreds of millions of people, are calling on governments in an open letter [1] to urgently take action to shut down this threat. 

Aid

Revelations in CDC Group annual report mean £668m of UK aid has financed fossil fuels overseas since Paris Agreement

Campaign group Global Justice Now has condemned new revelations of the UK government putting aid money into fossil fuel projects overseas in today’s annual report of CDC Group, the UK’s development bank.(1)

The report lists CDC investments including £65.5m in Early Power Limited, a gas power station in Ghana, and £34.9m in the gas-fired Azito power plant operated by CDC subsidiary Globeleq Limited in Cote d'Ivoire.

Reacting to US pharma company Gilead's announcement of global pricing for its remdesivir drug, Nick Dearden, director of Global Justice Now, said:

"Remdesivir is a drug which has been produced with substantial amounts of public money in the US, and which researchers have estimated could be made for $9 per treatment course (1), but here is Big Pharma company Gilead generously only charging over $2,000! While that is reduced to $600 in lower-income countries, these are still vast price tags.